Nanci Mae Miller

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Novel agents for the treatment of immune-mediated diseases such as systemic lupus erythematosus (SLE) have been increasingly used as an alternative to or in combination with conventional therapies. Belimumab, a human monoclonal antibody that inhibits B-cell activating factor (BAFF), has demonstrated efficacy in moderate-to-severe SLE with similar adverse(More)
  • 1